109 related articles for article (PubMed ID: 8206267)
1. Secretion of cathepsin B and tumour invasion.
Keppler D; Abrahamson M; Sordat B
Biochem Soc Trans; 1994 Feb; 22(1):43-9. PubMed ID: 8206267
[No Abstract] [Full Text] [Related]
2. Latency of cathepsin B secreted by human colon carcinoma cells is not linked to secretion of cystatin C and is relieved by neutrophil elastase.
Keppler D; Waridel P; Abrahamson M; Bachmann D; Berdoz J; Sordat B
Biochim Biophys Acta; 1994 May; 1226(2):117-25. PubMed ID: 8204657
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and secretion of procathepsin B and cystatin C by human bronchial epithelial cells in vitro: modulation of cathepsin B activity by neutrophil elastase.
Burnett D; Abrahamson M; Devalia JL; Sapsford RJ; Davies RJ; Buttle DJ
Arch Biochem Biophys; 1995 Feb; 317(1):305-10. PubMed ID: 7872798
[TBL] [Abstract][Full Text] [Related]
4. Human sputum cathepsin B degrades proteoglycan, is inhibited by alpha 2-macroglobulin and is modulated by neutrophil elastase cleavage of cathepsin B precursor and cystatin C.
Buttle DJ; Abrahamson M; Burnett D; Mort JS; Barrett AJ; Dando PM; Hill SL
Biochem J; 1991 Jun; 276 ( Pt 2)(Pt 2):325-31. PubMed ID: 1710889
[TBL] [Abstract][Full Text] [Related]
5. In vitro activation of pro-cathepsin B by three serine proteinases: leucocyte elastase, cathepsin G, and the urokinase-type plasminogen activator.
Dalet-Fumeron V; Guinec N; Pagano M
FEBS Lett; 1993 Oct; 332(3):251-4. PubMed ID: 8405467
[TBL] [Abstract][Full Text] [Related]
6. Levels of neutrophil elastase and cathepsin B activities, and cystatins in human sputum: relationship to inflammation.
Buttle DJ; Burnett D; Abrahamson M
Scand J Clin Lab Invest; 1990 Sep; 50(5):509-16. PubMed ID: 2237263
[TBL] [Abstract][Full Text] [Related]
7. Expression of cathepsin B and cystatin C in human breast cancer.
Yano M; Hirai K; Naito Z; Yokoyama M; Ishiwata T; Shiraki Y; Inokuchi M; Asano G
Surg Today; 2001; 31(5):385-9. PubMed ID: 11381499
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil lysosomal dysfunctions in mutant C57 Bl/6J mice: interstrain variations in content of lysosomal elastase, cathepsin G and their inhibitors.
Gardi C; Cavarra E; Calzoni P; Marcolongo P; de Santi M; Martorana PA; Lungarella G
Biochem J; 1994 Apr; 299 ( Pt 1)(Pt 1):237-45. PubMed ID: 8166647
[TBL] [Abstract][Full Text] [Related]
9. Cathepsin B activates human trypsinogen 1 but not proelastase 2 or procarboxypeptidase B.
Lindkvist B; Fajardo I; Pejler G; Borgström A
Pancreatology; 2006; 6(3):224-31. PubMed ID: 16534247
[TBL] [Abstract][Full Text] [Related]
10. V-ATPase inhibition by archazolid leads to lysosomal dysfunction resulting in impaired cathepsin B activation in vivo.
Kubisch R; Fröhlich T; Arnold GJ; Schreiner L; von Schwarzenberg K; Roidl A; Vollmar AM; Wagner E
Int J Cancer; 2014 May; 134(10):2478-88. PubMed ID: 24166050
[TBL] [Abstract][Full Text] [Related]
11. Cathepsin B-indicator for the release of lysosomal cysteine proteinases in severe trauma and inflammation.
Assfalg-Machleidt I; Jochum M; Nast-Kolb D; Siebeck M; Billing A; Joka T; Rothe G; Valet G; Zauner R; Scheuber HP
Biol Chem Hoppe Seyler; 1990 May; 371 Suppl():211-22. PubMed ID: 2400584
[No Abstract] [Full Text] [Related]
12. Cathepsin B generates the most common form of amyloid A (76 residues) as a degradation product from serum amyloid A.
Yamada T; Liepnieks JJ; Kluve-Beckerman B; Benson MD
Scand J Immunol; 1995 Jan; 41(1):94-7. PubMed ID: 7824894
[TBL] [Abstract][Full Text] [Related]
13. The expression of cathepsin B and other lysosomal proteinases in normal tissues and in tumors.
Qian F; Chan SJ; Gong QM; Bajkowski AS; Steiner DF; Frankfater A
Biomed Biochim Acta; 1991; 50(4-6):531-40. PubMed ID: 1801719
[TBL] [Abstract][Full Text] [Related]
14. Intracellular transport and processing of lysosomal cathepsin B.
Nishimura Y; Kato K
Biochem Biophys Res Commun; 1987 Oct; 148(1):254-9. PubMed ID: 3675577
[TBL] [Abstract][Full Text] [Related]
15. Activity of lysosomal and nonlysosomal proteases and contents of protein and its degradation products in the blood serum of rats with fibrosarcoma induced by methylcholanthrene.
Gołaszewski Z; Pałka J; Sobolewski K; Ostrowska H; Gołaszewska J
Rocz Akad Med Bialymst; 1997; 42(1):218-24. PubMed ID: 9581483
[TBL] [Abstract][Full Text] [Related]
16. Cathepsin B and cystatins: evidence for a role in cancer progression.
Sloane BF
Semin Cancer Biol; 1990 Apr; 1(2):137-52. PubMed ID: 2103490
[TBL] [Abstract][Full Text] [Related]
17. [Cathepsin B and neoplasm invasiveness].
Poreba W; Gawlik K; Gutowicz J
Postepy Biochem; 2002; 48(2):111-20. PubMed ID: 12362601
[No Abstract] [Full Text] [Related]
18. Molecular regulation of human cathepsin B: implication in pathologies.
Yan S; Sloane BF
Biol Chem; 2003 Jun; 384(6):845-54. PubMed ID: 12887051
[TBL] [Abstract][Full Text] [Related]
19. Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor.
Foghsgaard L; Wissing D; Mauch D; Lademann U; Bastholm L; Boes M; Elling F; Leist M; Jäättelä M
J Cell Biol; 2001 May; 153(5):999-1010. PubMed ID: 11381085
[TBL] [Abstract][Full Text] [Related]
20. [The lysosomal cathepsins B, L and D in development of murine experimental leukemias].
Khalikova TA; Korolenko TA; Il'nitskaia SI
Biomed Khim; 2009; 55(5):621-34. PubMed ID: 20017393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
